Short-selling firm Muddy Waters said in a legal brief that outside cyber security experts it hired have validated its claim that St. Jude Medical Inc. cardiac implants are vulnerable to potentially life-threatening cyber attacks.
The U.S. FDA placed a partial hold on Berkeley, Calif.-based Aduro Biotech’s LADD trials.
GlaxoSmithKline has filed its shingles vaccine Shingrix for U.S. regulatory approval, bringing the potential $1 billion-a-year seller a step closer to market.
Former Democratic presidential candidate Bernie Sanders, in an opinion editorial published in the Los Angeles Times, urged Californians to approve a November ballot measure aimed at reining in pharmaceutical prices.
Two companies making vaccines to help the world eradicate polio are failing to produce enough, so many countries should prepare to give lower doses to make stocks last, a group of experts has advised the World Health Organization.
Heart attack survivors who participate in cardiac rehabilitation programs may survive longer, but feel no healthier, than they would without this follow-up care, a U.S. study suggests.
The World Medical Association (WMA), the top medical-ethics body, installed an Indian doctor facing corruption charges as its president despite controversy surrounding his appointment while legal cases are pending.
Before there are new therapies to set a firm apart, there is a far more fundamental need that competitiveness will ultimately hinge on: high-quality, diversified, annotated human biospecimens.
Merck & Co. ended a Phase III trial of Keytruda in advanced urothelial cancer because the immuno-oncology drug met its primary endpoint.
Alkermes’ experimental anti-depression drug ALKS-5461 significantly reduced symptoms in major depressive disorder patients not helped by standard treatments.
Former Democratic presidential candidate Bernie Sanders and U.S. Representative Elijah Cummings issued a letter seeking information from Ariad Pharmaceuticals Inc. on the “staggering” price increases for the company’s leukemia drug.
President Barack Obama said his departure from office in January might be what it takes to begin to heal the political scars over Obamacare and allow for needed fixes to his signature healthcare law.
Gilead announced high cure rates across all types of hepatitis C in late-stage studies testing a triple drug combo; another experimental drug showed promise in reducing liver scarring in a mid-stage trial.
Swiss drugmaker Roche’s bid to follow its blockbuster cancer drug Avastin with a newer, better drug took a hit when it announced that an investigational therapy had failed in a study against metastatic colorectal cancer (mCRC).
Roche said strong sales of new medicines like cancer immunotherapy drug Tecentriq would help to sustain the company’s growth as patents on older drugs start to expire.
In January 2013, after a long struggle with severe depression, my boyfriend took his own life. When someone you love commits suicide, there’s no handbook, no rules, no guidance for how to handle it.
Rigel Pharmaceuticals Inc. said its lead drug to treat a bleeding disorder failed in a second late-stage trial, sending its shares tumbling 32 percent in premarket trading.
Ghent, Belgium-based Ablynx announced that it is wrapping up its Phase II trials and starting meetings with U.S. and European regulators about its anti-IL-6R Nanobody, vobarilizumab, in rheumatoid arthritis (RA).
Roche confirmed its full-year 2016 outlook on the strength of robust sales of cancer drugs including Tecentriq, the new immunotherapy that the Swiss company is banking on to counter patent expirations of its older medicines.
Two doses of a vaccine that protects against cervical and several other types of cancer are enough for 11-to 12-year-olds, rather than the previous three-shot regimen, the U.S. Centers for Disease Control and Prevention said.